Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
| ▸ | ACLY | P53396 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29756085 | 1.00 | PTPN1 (0.45) | PTPN1STAT3ACLY | |
| SCHEMBL377474 | 1.00 | PTPN1 (0.45) | PTPN1STAT3ACLY | |
| SCHEMBL21757939 | 0.78 | PTPN1 (0.40) | PTPN1STAT3 | |
| SCHEMBL30455949 | 0.78 | PTPN1 (0.40) | PTPN1STAT3 | |
| SCHEMBL158316 | 0.75 | NR1I2 (0.37) | PTPN1 | |
| SCHEMBL29349988 | 0.75 | NR1I2 (0.37) | PTPN1 | |
| SCHEMBL29456643 | 0.75 | NR1I2 (0.37) | PTPN1 | |
| SCHEMBL13767028 | 0.74 | STAT3 (0.38) | PTPN1STAT3 | |
| SCHEMBL19117757 | 0.74 | STAT3 (0.41) | PTPN1STAT3 | |
| SCHEMBL3092052 | 0.74 | STAT3 (0.41) | PTPN1STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240050393-A1 | COMPOSITIONS AND USES THEREOF FOR TREATING OR PREVENTING VIRAL INFECTIONS | GILVERDI - HEALTH AND BEAUTY LTD (IL) | 2024-02-15 | — | — | US | claimed |
| WO-2022137241-A1 | COMPOSITIONS AND USES THEREOF FOR TREATING OR PREVENTING VIRAL INFECTIONS | GILVERDI - HEALTH AND BEAUTY LTD (IL) | 2022-06-30 | — | — | WO | claimed |
| WO-2020081357-A1 | BEVERAGE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Golden Spice Liquors LLC (US) | 2020-04-23 | — | — | WO | claimed |
| US-20200115663-A1 | BEVERAGE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Golden Spice Liquors LLC | 2020-04-16 | — | — | US | claimed |
| US-20100093870-A1 | HERBAL MEDICAMENTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISORDERS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2010-04-15 | — | — | US | claimed |
| CN-100528149-C | A composition for treating neurocerebrovascular disorders | COUNCIL SCIENT IND RES (IN) | 2009-08-19 | — | — | CN | claimed |
| EP-1453528-B1 | COMPOSITIONS CONTAINING CURCUMA EXTRACTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISORDERS | COUNCIL SCIENT IND RES (IN) | 2009-07-22 | — | — | EP | claimed |
| US-20080312333-A1 | Agent for Preventing/Ameliorating Life Style-Related Diseases Containing Turmeric Essential Oil Component | KANEKA CORPORATION (JP) | 2008-12-18 | — | — | US | claimed |
| EP-1752144-A1 | AGENT FOR PREVENTING/AMELIORATIG LIFE STYLE-RELAETD DISEASES CONTAINING TURMERIC ESSENTIAL OIL COMPONENT | Kaneka Corporation (JP) | 2007-02-14 | — | — | EP | claimed |
| US-20060051438-A1 | Herbal medicaments for the treatment of neurocerebrovascular disorders | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2006-03-09 | — | — | US | claimed |
| US-6991814-B2 | Herbal medicaments for the treatment of neurocerebrovascular disorders | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-01-31 | — | — | US | claimed |
| CN-1615144-A | A composition for treating neurocerebrovascular disorders | COUNCIL SCIENT IND RES (IN) | 2005-05-11 | — | — | CN | claimed |
| EP-1453528-A2 | COMPOSITIONS CONTAINING CURCUMA EXTRACTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISORDERS | Council of Scientific and Industrial Research (IN) | 2004-09-08 | — | — | EP | claimed |
| US-20040033277-A1 | Herbal medicaments for the treatment of neurocerebrovascular disorders | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH | 2004-02-19 | — | — | US | claimed |
| WO-2003051380-A2 | COMPOSITIONS CONTAINEING CURCUMA EXTRACTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISORDERS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-06-26 | — | — | WO | claimed |
| EP-4376973-B1 | MOLECULARLY IMPRINTED POLYMER, AND ITS USE IN THE QUANTIFICATION OF A PESTICIDE IN A SAMPLE | ECOLE SUPERIEURE PHYSIQUE & CHIMIE IND VILLE DE PARIS (FR) | 2025-07-02 | — | — | EP | disclosed |
| WO-2025133916-A1 | TURMERIC OIL ESSENTIAL-OIL BISABOLENE SESQUITERPENOIDS IN THE TREATMENT OF NON-NEURODEGENERATIVE DISEASES | UNIVERSIDAD DE CUENCA (EC) | 2025-06-26 | — | — | WO | disclosed |
| US-20040033277-A1 | Herbal medicaments for the treatment of neurocerebrovascular disorders | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH | 2004-02-19 | — | — | US | disclosed |
| WO-2003051380-A2 | COMPOSITIONS CONTAINEING CURCUMA EXTRACTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISORDERS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003051380-A2 | COMPOSITIONS CONTAINEING CURCUMA EXTRACTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISORDERS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060051438-A1 | Herbal medicaments for the treatment of neurocerebrovascular disorders | NR0B1, NR0B2, CYP46A1 | PTPN1 4865/4885STAT3 1658/4885ACLY 3292/4885 |
| US-20100093870-A1 | HERBAL MEDICAMENTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISORDERS | NR0B1, NR0B2, CYP46A1 | PTPN1 4865/4885STAT3 1658/4885ACLY 3292/4885 |
| US-20040033277-A1 | Herbal medicaments for the treatment of neurocerebrovascular disorders | NR0B1, NR0B2, CYP46A1 | PTPN1 4865/4885STAT3 1658/4885ACLY 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.